<DOC>
<DOCNO>
EP-0000770
</DOCNO>
<TEXT>
<DATE>
19790221
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/7076 A61P-37/00 A61P-25/00 A61P-29/00 A61P-37/08 A61P-9/00 C07H-19/052 C07H-19/16 C07H-19/00 A61P-9/12 A61P-21/00 A61K-31/70 A61P-25/26 A61P-21/02 A61K-31/7042 C07H-19/167 A61K-31/7052 
</IPC-CLASSIFICATIONS>
<TITLE>
1-methylisoguanosin, processes and intermediates for its preparation, its pharmaceutical compositions and their preparation
</TITLE>
<APPLICANT>
hoffmann la rochech <sep>f.hoffmann-la roche & co. aktiengesellschaft<sep>f. hoffmann-la roche &amp; co. aktiengesellschaft postfach 3255 4002 basel ch<sep>
</APPLICANT>
<INVENTOR>
cook alan frederickus<sep>gregson richard peterau<sep>quinn ronald jamesau<sep>cook, alan frederick<sep>gregson, richard peter<sep>quinn, ronald james<sep>cook, alan frederick19 hillcrest roadcedar grove, n.j.07009us<sep>gregson, richard peter22 towradgi streetnarraweena, n.s.w.au<sep>quinn, ronald james9 boylson placecromer, n.s.w.au<sep>
</INVENTOR>
<ABSTRACT>
1-methylisoguanosine is prepared by isolation from natural sources in a conventional manner or by a chemical process.  1-methyl- isoguanosine can be used as muscle relaxant and/or as agent for influencing the central nervous system and/or as antiinflammatory and/or antiallergic and/or hypotensive agent. 
</ABSTRACT>
</TEXT>
</DOC>
